Define “Restore”: Canada’s New Remedies Standard for Mergers
On December 5, Axinn partner Craig Minerva will speak on the virtual panel, “Define ‘Restore’: Canada’s New Remedies Standard for Mergers,” hosted by the Canadian Bar Association.
Jimmy Attridge Named to Washingtonian Magazine’s 2024 Top Lawyers List
Axinn partner Jimmy Attridge has been named to Washingtonian’s 2024 “Top Lawyers” list for antitrust. According to the publication, those recognized “are the legal pros you’d want in your corner.”
United States: FTC and DOJ Double Down on Aggressive Antitrust Enforcement in Final Year of Biden Administration
Axinn partners Lisl Dunlop, Bradley Justus, and James Hunsberger and associates Aigerim Saudabayeva and Megan Walden wrote the introduction and the United States overview of Global Competition Review’s Market Review: Merger Control 2024.
Define “Restore”: Canada’s New Remedies Standard for Mergers
On December 5, Axinn partner Craig Minerva will speak on the virtual panel, “Define ‘Restore’: Canada’s New Remedies Standard for Mergers,” hosted by the Canadian Bar Association.
Jimmy Attridge Named to Washingtonian Magazine’s 2024 Top Lawyers List
Axinn partner Jimmy Attridge has been named to Washingtonian’s 2024 “Top Lawyers” list for antitrust. According to the publication, those recognized “are the legal pros you’d want in your corner.”
United States: FTC and DOJ Double Down on Aggressive Antitrust Enforcement in Final Year of Biden Administration
Axinn partners Lisl Dunlop, Bradley Justus, and James Hunsberger and associates Aigerim Saudabayeva and Megan Walden wrote the introduction and the United States overview of Global Competition Review’s Market Review: Merger Control 2024.
Define “Restore”: Canada’s New Remedies Standard for Mergers
On December 5, Axinn partner Craig Minerva will speak on the virtual panel, “Define ‘Restore’: Canada’s New Remedies Standard for Mergers,” hosted by the Canadian Bar Association.
Antitrust
Axinn’s full-service antitrust practice stands among the largest and most experienced. Our team works coast to coast and across borders to deliver integrated counsel on mergers and acquisitions (M&A), litigation, and government investigations.
Global Leader in Antitrust
Celebrated as a top-ranked antitrust practice by Chambers and Partners and Global Competition Review, Axinn is renowned for representing some of the world’s largest companies in matters of the highest strategic importance. Our track record of success includes leading high-profile civil and criminal litigations and investigations. Orchestrating approximately half a trillion dollars in M&A transactions, we have gained clearances for intensely contested deals, including the largest cash merger in U.S. history, the largest-ever tech deal, and other landmark transactions.
Unmatched Experience
We don't just understand the government authorities you'll face – we have inside agency experience. Our team of more than 70 dedicated antitrust lawyers includes former high-ranking officials from the Federal Trade Commission (FTC) and U.S. Department of Justice (DOJ) as well as European Union antitrust regulators. Our dual perspective and experience enable us to tackle the most challenging multinational antitrust issues.
Deep Commitment to Client Success
Invested in our clients' success, we provide in-depth analysis and dedicated advocacy. Our inquisitive and incisive approach enables us to navigate the most complex legal issues with precision. We value collaboration and inclusivity, evidenced by our success in leading multijurisdictional teams to resolve sprawling litigations and advance cross-border deals.
Our reputation as tenacious advocates for strategic transactions is built on our track record of obtaining global clearances for multibillion-dollar deals combining industry rivals.
Axinn lawyers regularly serve as lead counsel, overseeing co-counsel around the world. Our diverse perspectives and experience make us adept at developing cohesive strategies to address regulators’ concerns head-on and gain approvals in the most challenging jurisdictions.
Experience:
- Broadcom’s $69 billion acquisition of VMware.
- Dell’s $67 billion acquisition of EMC.
- Thermo Fisher Scientific’s $13.2 billion acquisition of Life Technologies and $12.5 billion tender offer to acquire QIAGEN .
Axinn’s substantial experience as lead counsel in Section 7 challenges to mergers includes:
- Obtained a judgment rejecting the DOJ’s bid to block SunGard’s $825 million acquisition of Comdisco’s business recovery assets.
- Successfully litigated against the DOJ’s attempt to block George’s Inc.'s sale of assets to Tyson Foods after the sale had been completed.
- Successfully litigated against the City of New York in its efforts to stop Group Health Inc.'s acquisition of HIP Insurance Company.
Employing a sophisticated yet practical approach, Axinn has defended major industry players in some of the most high-profile and complex antitrust litigations and deal reviews in recent history. From private treble-damage class actions and sprawling multidistrict litigations (MDL) to price-fixing, bid-rigging, market allocation, and other antitrust claims, we resolve cases strategically and efficiently. Our experience extends to monopolization disputes, merger trials, criminal defense, and internal investigations.
Our inquisitive nature drives us to explore all facets of antitrust claims, ensuring comprehensive and diligent representation across industries. We consistently apply our creativity and bottom-line perspective to achieve exceptional outcomes in matters involving third-party subpoena defenses, leniency applications, antitrust compliance, and government investigations.
Experience:
- Representing Tyson Foods in multiple class action lawsuits alleging collusion among competitors.
- Representing Alvogen in the sprawling Generic Drugs MDL and in its antitrust counterclaims against Indivior relating to Alvogen’s launch of a generic equivalent to SUBOXONE®sublingual film.
- Representing Momenta Pharmaceuticals in a monopolization and class action lawsuit.
In today’s aggressive enforcement environment, the choice of cartel counsel is crucial. Lawyers must be incisive advisors, inquisitive strategists, and invested advocates. Axinn embodies these qualities.
We pride ourselves on handling the two largest price-fixing investigations of the past decade. We’ve represented clients in cartel investigations by major global authorities, including:
- DOJ
- Australian Competition and Consumer Commission
- Brazil’s Administrative Council for Economic Defense
- Canadian Competition Bureau
- European Commission
Our ranks include former federal prosecutors and leaders from the DOJ Antitrust Division who have overseen criminal investigations, trials, and policy initiatives. Leveraging our government experience, we take an integrated approach to managing all aspects of representation: compliance programs; internal investigations; government probes; criminal proceedings; and civil litigation.
We understand that each client’s goals and challenges are unique and devise tailored, creative strategies to resolve investigations.
We excel in leading complex matters at the intersection of antitrust and intellectual property (IP) laws. Combining our advanced technical training and focused IP experience, we regularly advise on standard-setting and fair, reasonable, and nondiscriminatory issues.
Clients call on us to conduct thorough internal investigations and to develop and implement robust antitrust compliance programs. Our client-centric approach empowers clients to navigate the most challenging antitrust landscapes with confidence.
Experience:
- Representing Google before FTC with respect to Standard Essential Patents
- Representing Red Hat before DOJ with respect to patent acquisitions
- Representing Motorola Mobility before FTC regarding patent issues
Insights
Event
|February 27, 2025
American Bar Association 2025 Asia-Pacific Conference
On February 28, Axinn partner Tiffany Rider will speak on the "Ready for a Dawn Raid in the Digital Era?" panel at the American Bar Association's Asia-Pacific Conference, being held February 26-28 in Singapore. ...Read more
Event
|February 20, 2025
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Axinn is pleased to announce its sponsorship of the National Bar Association Commercial Law Section's Corporate Counsel Conference, being held February 20-22 in Fajardo, Puerto Rico. ...Read more
Event
|January 30, 2025
GCR Live: Law Leaders Global 2025
On January 30, Axinn partner Bradley Justus will speak on the "Antitrust: Theories of Harm in Unilateral Conduct Cases Concerning Big Tech in the U.S. and Europe" panel at Global Competition Review's Law Leaders Global Conference, being held January 29-31 in Miami. ...Read more
Event
|January 26, 2025
SABA North America Corporate Counsel Retreat 2025
Axinn is pleased to announce its sponsorship of the South Asian Bar Association of North America’s Corporate Counsel Retreat, being held January 26-28 in Charlotte, North Carolina. ...Read more
Publications
|December 20, 2024
|less than 1 min read
Forecasting Health Care Antitrust Under a Second Trump Administration
Partner Lisl Dunlop speaks with Mark Seidman, partner at Weil Gotshal & Manges LLP, for the American Health Law Association's Speaking of Health Law podcast about some of the potential health care antitrust priorities of a second Trump Administration. They discuss the incoming administration’s potential approaches to the new Merger Guidelines, hospital merger enforcement, focus on labor market impacts, private equity in health care, and the FTC’s rule banning non-competes....Read more
News
|December 17, 2024
|1 min read
GCR 100 2025 Ranks Axinn Antitrust Group in Top Categories
Axinn is pleased to announce that its prominent Antitrust practice has been named one of the top antitrust practices globally in Global Competition Review's 2025 GCR 100. Global Competition Review ranked the firm’s New York antitrust practice as Elite, and the Washington, DC antitrust practice was ranked Highly Recommended. The firm "remains a go-to firm for the most complex competition matters,” according to Global Competition Review....Read more
Publications
|December 16, 2024
|less than 1 min read
What Trump’s FTC Picks Mean for Bio-Pharma Dealmaking and PBMs
Axinn managing partner Jeny Maier was quoted in the Endpoint News article, "What Trump’s FTC Picks Mean for Bio-Pharma Dealmaking and PBMs."...Read more
Event
|December 12, 2024
Capitol Forum Health Care Competition Conference 2024
On December 12, Axinn partner Lisl Dunlop will speak on the "PBM Litigation and Legislation: Federal and State Outlook" panel at Capitol Forum's Health Care Competition Conference in Washington, DC. ...Read more
Publications
|December 11, 2024
|less than 1 min read
Albertsons Ends Merger Deal, Accuses Kroger of ‘Self-Serving Conduct’
Axinn antitrust practice chair Mike Keeley was quoted in The Washington Post article, "Albertsons Ends Merger Deal, Accuses Kroger of ‘Self-Serving Conduct’"...Read more
December 9, 2024
|1 min read
Practice Chair
Featured Insights
Featured Insights
American Bar Association 2025 Asia-Pacific Conference
Speaking Engagement
Antitrust
NBA Commercial Law Section 38th Annual Corporate Counsel Conference
Sponsorship
Antitrust
GCR Live: Law Leaders Global 2025
Speaking Engagement
Antitrust
SABA North America Corporate Counsel Retreat 2025
Sponsorship
Antitrust
Forecasting Health Care Antitrust Under a Second Trump Administration
Podcast
Antitrust
GCR 100 2025 Ranks Axinn Antitrust Group in Top Categories
Awards & Recognitions
Antitrust
What Trump’s FTC Picks Mean for Bio-Pharma Dealmaking and PBMs
Media Mentions
Antitrust
Capitol Forum Health Care Competition Conference 2024
Speaking Engagement
Antitrust
Ethical Considerations for Cybersecurity, IP Transactions and Avoiding USPTO Sanctions (EIP241212)
Speaking Engagement
Intellectual Property
Albertsons Ends Merger Deal, Accuses Kroger of ‘Self-Serving Conduct’
Media Mentions
Antitrust